Publication: 3897

Publication: 3897

Plasma 25-hydroxyvitamin D levels and survival in stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Clin Cancer Res vol 29 (14) 2621-2630

Year:: 2023
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: Alliance-data-source,-internal-user
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 12

Parents:: 3714
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:: Pfizer
Grants:: U10CA180821, U10CA180882, U24CA196171, UG1CA189858, UG1CA189960, UG1CA233163, UG1CA233180, UG1 CA233320, UG1CA233290, UG1CA233337, UG1CA233339; UG1CA233234, U10CA180863, CCS Grant # 707213(CCTG); U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888, UG1CA233163(SWOG), R01CA205406, R33CA160344, P30 CA008748, P30 CA015083

Corr. Author:
Authors:: Qiao-Li Wang Chao Ma Chen Yuan Qian Shi Brian M. Wolpin Yin Zhang Charles S. Fuchs Jeffrey Meyer Tyler Zemla En Cheng Priya Kumthekar Katherine A. Guthrie Felix Couture Philip Kuebler Pankaj Kumar Benjamin Tan Smitha Krishnamurthi Richard M. Goldberg Alan Venook Charles Blanke Anthony F. Shields Eileen M. O'Reilly Jeffrey A. Meyerhardt Kimmie Ng

Networks:: CA824, HEARTLAND, LAPS-CT018, LAPS-IL036, LAPS-MA036, LAPS-MD017, LAPS-MO011, LAPS-NY016, LAPS-OH007, OH027, OR013

Study: Alliance-A151939
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-80702
Phases:: N/A, 3

Keywords:: colon adenocarcinoma, recurrence, survival, 25(OH)D, inflammation, biomarker